IBRN

iShares Neuroscience and Healthcare ETF

$29.61
+0.00%
Market closed. Last update: 10:54 PM ET

📎 Investment Objective

The iShares Neuroscience and Healthcare ETF (IBRN) seeks to provide exposure to companies involved in the research, development, and production of treatments and technologies related to neuroscience and healthcare.

Overview

ETF tracking iShares Neuroscience and Healthcare ETF

Category Healthcare
Issuer BlackRock
Inception Date 2022-08-26
Market Cap $4.4M
Average Volume N/A
Dividend Yield 0.34%
52-Week Range $18.44 - $30.41
VWAP $29.08

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

The iShares Neuroscience and Healthcare ETF (IBRN) seeks to provide exposure to companies involved in the research, development, and production of treatments and technologies related to neuroscience and healthcare.

🎯 Investment Strategy

The ETF tracks the Morningstar Neuroscience and Healthcare Index, which is composed of global companies across the healthcare and neuroscience sectors. The fund aims to replicate the performance of this index by investing in the underlying securities.

✨ Key Features

  • Provides diversified exposure to the neuroscience and healthcare industries
  • Invests in companies involved in the development of treatments, technologies, and services related to neurological conditions and overall healthcare
  • Passively managed to track the Morningstar Neuroscience and Healthcare Index
  • Low expense ratio of 0.00%

⚠️ Primary Risks

  • Sector concentration risk as the fund is focused on the healthcare and neuroscience industries
  • Potential volatility due to the specialized nature of the underlying companies
  • Liquidity risk as the fund is relatively new and has low assets under management
  • Tracking error risk as the fund may not perfectly replicate the performance of the underlying index

👤 Best For

This ETF may be suitable for investors seeking exposure to the healthcare and neuroscience sectors as part of a diversified portfolio. It may be of particular interest to investors with a long-term investment horizon and a higher risk tolerance, as the specialized nature of the underlying companies can lead to increased volatility.